The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Special Report' as President-elect Donald ...

The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, reaching US$2.45 billion in 2024 and an impressive US$11.52 billion by 2030. The ...

Bengaluru-based cell and gene therapy start-up Immuneel Therapeutics on Monday announced the launch of Qartemi -- the countr ...

Immuneel Therapeutics, the start-up, backed by Kiran Mazumdar-Shaw, was the first in India to conduct CAR T-cell therapy ...

Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Results from a study funded by the International Nut and Dried Fruit Council have been published in the journal Nutrients.[1] The study showed that longer-term consumption of mixed nuts may lower ...

Football legends Michael Vick and Michael Strahan are set to enter the College Football Hall of Fame.

There has been tremendous interest in cell-based meat, not least for its touted long-term potential to aid world food ...